SCHEMBL6842783

SCHEMBL6842783

Cc1nc2scc(C)n2c1-c1nc(-c2ccccc2)c(-c2nnc[nH]2)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.42
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 3/20 0.37
HSD17B10 Q99714 3/20 0.37
RXFP1 Q9HBX9 1/20 0.35
CDC7 O00311 2/20 0.33
DBF4 Q9UBU7 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
RCE1 Q9Y256 1/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
COMT P21964 1/20 0.32
RAB9A P51151 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CG P48736 1/20 0.31
MEN1 O00255 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16937992 0.84 PTGS2 (0.42) PTGS2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL953702 0.82 PTGS2 (0.42) PTGS2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL954999 0.82 PTGS2 (0.42) PTGS2ALDH1A1HSD17B10SMN1; SMN2TSHR
SCHEMBL952215 0.78 ALDH1A1 (0.41) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
Hydrochloric Acid SCHEMBL952112 0.77 ALDH1A1 (0.41) KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL952713 0.76 AKT1 (0.35) KDM4EALDH1A1CDC7DBF4SMN1; SMN2
SCHEMBL6842781 0.75 AKT1 (0.38) KDM4ECDC7DBF4SMN1; SMN2NPC1
SCHEMBL955207 0.74 AKT1 (0.31)
SCHEMBL953829 0.73 PTGS2 (0.43) PTGS2ALDH1A1TSHR
SCHEMBL6842718 0.71 KDM5B (0.32) KDM4EALDH1A1CDC7DBF4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139589-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-09-22 US disclosed
US-9139589-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-09-22 US disclosed
US-9090601-B2 Thiazole derivatives MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-07-28 US disclosed
US-9090601-B2 Thiazole derivatives MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-07-28 US disclosed
US-20110003807-A1 Thiazole derivatives MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed
US-20110003807-A1 Thiazole derivatives MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed
US-20110003806-A1 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed
US-20110003806-A1 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed
WO-2010090716-A1 HETEROARYLS AND THEIR USE AS PI3K INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003807-A1 Thiazole derivatives MTOR, RICTOR, AKT2 PTGS2 2116/4885KDM4E 1981/4885ALDH1A1 1687/4885
US-20110003806-A1 Heteroaryls and uses thereof RICTOR, MTOR, AKT1S1 PTGS2 310/4885KDM4E 2304/4885ALDH1A1 728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.